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Ways & MeansRational Protein Crystallization
by Mutational Surface Engineering
directly correlated with the number of conditions tested
(Segelke, 2001). Proteins that crystallize easily often do
so with rather simple, commercially available screens. It
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(Jancarik and Kim, 1991). In contrast, for proteins recal-
citrant to crystallization, little is gained by extending
the range of conditions. As the proverbial “low-hangingSummary
fruit,” i.e., easily crystallized small- to medium-sized pro-
teins, falls prey to high-throughput efforts, the “high-Protein crystallization constitutes a limiting step in
hanging fruit” presents an increasing challenge.structure determination by X-ray diffraction. Even if
One of the ways to address the problem of efficientsingle crystals are available, inadequate physical qual-
crystallization is homolog screening, pioneered over 50ity may seriously limit the resolution of the available
years ago (Campbell et al., 1972; Kendrew et al., 1954).data and consequently the accuracy of the atomic
The concept is simple: if you cannot grow crystals of themodel. Recent studies show that targeted mutagene-
protein you want, try growing crystals of a homologoussis of surface patches containing residues with large
protein with a similar or identical function. This ap-flexible side chains and their replacement with smaller
proach, while often successful, has some drawbacks.amino acids lead to effective preparation of X-ray qual-
It is not possible to predict, for example, if any of theity crystals of proteins otherwise recalcitrant to crys-
homologs crystallize easier or at all. Also, each newtallization. Furthermore, this technique can also be
gene must be subcloned with the purification proce-used to obtain crystals of superior quality as compared
dures determined from scratch. Finally, for drug designto those grown for the wild-type protein, sometimes
purposes and other studies, a protein from a hyperther-increasing the effective resolution by as much as 1 A˚
mophilic bacterium may be a relatively poor model foror more. Several recent examples of this new method-
a human homolog, with perhaps no more than 15%ology suggest that the method has the potential to
sequence identity.become a routine tool in protein crystallography.
An alternative approach is to modify the target protein
by recombinant methods. The first use of site-directed
Introduction mutagenesis for crystal engineering was reported by
Lawson et al. (1991), who reproduced crystal contacts
In spite of dramatic advances in macromolecular crys- from rat L ferritin in human ferritin H chain. A replacement
tallography over the last three decades, preparation of of Lys86, found in the human sequence, with Glu, which
well diffracting single crystals continues to be the time- occurs in rat, recreated a Ca2 binding bridge that medi-
limiting step. While structures can be often phased ates crystal contacts in the rat ortholog. Subsequently,
within minutes of rapid data collection experiments at McElroy et al. (1992) showed that mutagenesis of resi-
synchrotron beamlines (Dauter, 2002), the effort in- dues on the surface of thymidylate synthase resulted in
volved in the preparation of X-ray quality crystals re- dramatic changes in the protein’s behavior in crystalliza-
mains a substantial barrier to both high-throughput ap- tion screens. Although this and subsequent reports
proaches and problem-oriented investigations. Current clearly suggested an efficient experimental route, lack
estimates based on information from the Structural Ge- of specific protocols and guidelines as to how to alter
nomics Centers suggest that on average less than 30% the protein’s surface appears to have precluded wider
of proteins expressed in soluble form in E. coli form application of this strategy. Nonetheless, a number of
crystals, of which only a portion yield X-ray quality speci- proteins are known to have been crystallized in mutated
mens diffracting to 2.0 A˚ resolution or better (Dale et form when wild-type crystals were unavailable, often by
al., 2003). serendipity. For example, GroEL was crystallized using
As it is essentially impossible to predict crystallization samples with two mutations accidentally introduced by
conditions for any protein, the process relies on exten- PCR (Braig et al., 1994; Horwich, 2000).
sive screening of hundreds to thousands of conditions, We recently proposed a protocol for modification of
including different precipitants, buffers, etc. Thus, de- the surface of the target protein, involving local and
velopment of high-throughput crystallization robots, limited mutational exchange of large hydrophilic resi-
able to prepare over 100,000 samples per day while dues for alanines, as a rational strategy aimed at prepa-
miniaturizing the volumes, is often an integral part of ration of X-ray quality crystals. The procedure leads to
the structural genomics efforts (Stevens, 2000). While local reduction of conformational entropy and generates
these robots undoubtedly make an important impact contact-forming, conformationally homogeneous sur-
on high-throughput research, they do not necessarily face patches. The method shows considerable poten-
enhance the crystallization efficiency of new proteins tial, and to date allowed for the crystallization of several
because the success of protein crystallization is not novel proteins. It has also been used to generate new
crystal forms diffracting to much higher resolution than
the wild-type protein crystals. This paper is intended to*Correspondence: zsd4n@virginia.edu
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briefly review the novel strategy and selected examples minal fragment, RhoGDI is very difficult to crystallize,
and the known crystals of the wild-type domain diffractof its successful application.
to 2.5 A˚ with three molecules in the asymmetric unit
(Keep et al., 1997).Results
A number of mutants of RhoGDI with between one
and four Lys and/or Glu residues replaced with alaninesThe Concept of Rational Surface Engineering
were screened for crystallization properties (Longe-for Crystallization
necker et al., 2001a; Mateja et al., 2002). The multipleIn very general terms, the free energy change that drives
mutants involved residues sufficiently close together incrystallization can be expressed as a sum of three com-
sequence to allow for the use of a single primer in theponents:
QuikChange mutagenesis protocol. The results were
G  H  T(Sprotein  Ssolvent). very encouraging. Virtually every mutation significantly
altered the crystallization properties of RhoGDI (Figure
Given that the enthalpy values of intermolecular interac- 1). Single-site mutants showed significant differences
tions in the crystal lattice are typically small, crystalliza- in the kinetics of crystallization as compared to the wild-
tion is very sensitive to entropy changes involving both type protein, albeit without changing the crystal symme-
the solvent and the protein. Incorporation of protein try. In contrast, multiple mutations yielded a number of
molecules into the lattice carries a negative entropy new crystal forms. The crystal structures of selected
term, and this is an inescapable thermodynamic cost. mutants revealed that the new crystal forms contain
This unfavorable term may be overcome by positive crystals contacts formed directly by the mutated epi-
entropy from the release of water molecules bound to topes, as predicted by the hypothesis. Moreover, some
the protein as it is incorporated into the lattice. There of the crystals exhibited diffraction properties superior
is some evidence that the latter effects may at least in to the wild-type crystals, including the double-mutant
some cases exert a determining driving force in crystalli- E154A/E155A, which yielded data to 1.25 A˚ resolution
zation (Vekilov, 2003; Vekilov et al., 2002), even though (Mateja et al., 2002).
in absolute terms this may amount to the release of no
more than a few water molecules.
Crystallization of Novel ProteinsWhat is less appreciated is that the formation of crys-
by Surface Engineeringtal contacts involving ordering of surface side chains
The promising results obtained using the model systeminvolves further loss of entropy. Thus, a protein with a
of RhoGDI paved the way for the application of thesurface populated with larger hydrophilic residues may
technique to novel proteins, otherwise resistant to crys-in effect have an “entropy shield” preventing formation
tallization or yielding relatively low-quality crystals.of intermolecular contacts required for crystallization. It
Some of the examples of studies that were brought toshould therefore be possible to overcome this barrier
fruition by surface engineering include the following:by selective replacement of bulky surface residues with
small amino acids, e.g., Ala, with little or no conforma-
1. The RGSL Domain from PDZRhoGEF (Garrard et
tional entropy.
al., 2001; Longenecker et al., 2001b). The RGSL domains
Among the candidate exposed polar amino acids, ly-
target the proteins that contain them to the  subunits
sines and glutamates play a particular role. With very
of trimeric G proteins. The respective domain from the
few exceptions, they are located on the surface (Baud
guanine nucleotide exchange factor PDZRhoGEF would
and Karlin, 1999), they have a large solvent exposed
not crystallize in the wild-type form. Five mutants were
surface, and their side chains are characterized by high
prepared: E90A/K91A, E123A/E126A, E131A/E134A,
conformational entropy of 2 kcal/mol under normal
E171A/K172A, and K183A/E185A/E186A. All were ex-
conditions (Avbelj and Fele, 1998). Both lysines and glu-
pressed in E. coli, purified, and screened for crystalliza-
tamates are typically disfavored at interfaces in protein-
tion using the commercial Hampton Research Crystal
protein complexes (Conte et al., 1999), most probably
Screens I and II. Out of the five, the triple-mutant K183A/
because the entropic cost of their incorporation into an
E185A/E186A yielded high-quality single crystals straight
ordered interface is prohibitive. We hypothesized that
from the screen. The structure was readily solved by
Lys and Glu residues can constitute a good target for
MAD using SeMet-labeled protein, and revealed an inti-
surface modification and consequent crystal engi-
mate crystal contact formed by two symmetry-related
neering.
mutated loops (Figure 2).
2. The Yersinia pestis LcrV Antigen (Derewenda etThe Test Case—Human RhoGDI
In order to test the above hypothesis, we first studied al., 2004). LcrV (V antigen) is a multifunctional virulence
factor in Yersinia pestis, the causative agent of plague.the crystallization properties of a number of mutants of
the human protein RhoGDI—the Rho-specific guanine The protein regulates the translocation of cytotoxic ef-
fector proteins into the cytosol of mammalian cells vianucleotide exchange inhibitor. This relatively small pro-
tein (202 residues) contains a disordered N-terminal do- a type III secretion system and is an active and passive
mediator of resistance to disease. Several groups havemain and an immunoglobulin-like C-terminal domain
comprising 130 amino acids. The human RhoGDI has a unsuccessfully tried to crystallize wild-type LcrV. Five
multiple mutants (K40A/D41A/K42A, K54A/D55A/E57A,high combined Lys/Glu content of nearly 20% but is
not an exception in this regard among many cytosolic K72A/K73A, E155A/E156A/E159A, and K214A/E217A/
K218A) were made for the N-terminally truncated (1–regulatory proteins. Even without the disordered N-ter-
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Figure 1. A Selection of Crystals
Obtained using (A) K → A mutants and (B)
E→ A mutants of human RhoGDI. For details
see Longenecker et al. (2001a) and Mateja et
al. (2002).
23) LcrV protein, which has a wild-type activity. At the ditions diffracted to 2.2 A˚ resolution. These crystals were
used to solve the structure of LcrV by the MAD method.same time, to enhance sample homogeneity, the single
cysteine in LcrV (Cys274) was replaced with a serine The refined model of the LcrV structure reveals that the
epitope with the triple-surface mutation (K41A/D42A/residue. Four mutants gave “hits” in screens. One, K40A/
D41A/K42A, gave crystals that after optimization of con- K43A) mediates a crystal contact with the neighboring
Figure 2. The RGSL Domain of PDZRhoGEF
(A) Arrangement of two molecules related by
a 2-fold axis in the P6122 unit cell, showing
the three mutated sites.
(B) Close-up of the symmetric crystal contact.
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Figure 3. The Lcrv Antigen
(A) Packing of molecules in the P1 lattice.
(B) Details of the crystal contact involving the
mutated patch.
molecule. These three residues constitute the last turn 4. The CUE:Ubiquitin Complex (Prag et al., 2003). The
Hurley group at NIH used the surface modification strat-of helix -1, which forms an exposed knob that fits
between two adjacent molecule in the crystal lattice egy to obtain crystals of the complex of the CUE domain
of Vps9p with ubiquitin. The CUE domains are found in(Figure 3). The absence of the long side chains that
occupy these positions in the wild-type structure al- proteins participating in trafficking and ubiquitination
pathways. A single double mutant, K435A/K436A, waslowed the protein molecules to approach one another
without excessive loss of conformational entropy. generated, and its complex with ubiquitin yielded high-
quality crystals diffracting to 1.7 A˚ resolution, with two
3. The Product of YkoF Gene from B. subtilis (Y. CUE and two ubiquitin molecules in the asymmetric unit.
Devedjiev et al., submitted). This protein, one of the As in the other examples, the mutated epitopes are
targets of the Midwest Structural Genomics Center, involved in the crystal contacts, although no direct H
failed to yield crystals in the wild-type form. Two double bonds are seen. Instead, it appears that the lysines
mutants were prepared, K33A/K34A and K112A/E114A, found in the wild-type protein would have caused steric
and the former gave high-quality crystals diffracting to problems, and the proximity of other positively charged
1.6 A˚ resolution. The structure was solved readily by residues would have made this contact unfavorable.
MAD. The refined structure revealed a tertiary fold con-
taining an internal repeat of an (//)2 motif and a tightly 5. The Tyrosine Kinase Domain of the Insulin-like
Growth Factor-1 Receptor (Munshi et al., 2003). Theassociated homodimer in the asymmetric unit. The key
crystal contact occurs between the homodimers and is IGF-1R is a potential target for anticancer drug therapy
(Baserga, 1996). However, the crystal structure of themediated by the equivalent mutated surface patches
from each of the two molecules. The exposed backbone unphosphorylated apo form of the kinase domain was
solved at 2.7 A˚ resolution, too low for proper drug optimi-carbonyls create an ideal Ca2 binding site between the
molecules (Figure 4), and indeed Ca2 ions are required zation. The Merck investigators prepared three mutants,
K1025A/K1026A, E1067A/E1069A, and K1237A/E1238A/for these crystals to grow.
Ways & Means
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Figure 4. YkoF Crystal Structure
(A) Packing of molecules along the 21 axis
mediated by the Ca binding site.
(B) Details of the Ca-mediated crystal contact.
E1239A. Of these, the second double mutant yielded proximity to the amino acid sequence (Wang and Mal-
colm, 1999). While the prospects appear very promising,crystals diffracting to 1.5 A˚ resolution. Interestingly, the
1067/1069 sites occur at the N terminus of the kinase these results also raise important questions:
insert region, which in the wild-type crystals is disor-
dered. In contrast, in the mutant crystals, the fragment 1. How Do We Choose Sites for Mutagenesis?
is completely ordered. Comparison of the two structures As already pointed out, lysines and glutamates are found
shows that, in the wild-type lattice, E1067 and E1069 predominantly on the protein’s surface, with only 6%
would have been in proximity of E1253 and E1254, creat- and 12%, respectively, buried (Baud and Karlin, 1999).
ing an unstable negatively charged constellation. Thus, If two or more of these residues occur in close proximity
the reason for the crystallization of this mutant is similar as a cluster in the sequence, the surface location is a
to that behind the CUE:ubiquitin complex. virtual certainty. But which cluster to choose? Statisti-
cally, both residues occur preferentially in  helices and
turns, much less frequently in  structures. For lysines,Discussion
the distribution among , , and coil structures is 47%,
16%, and 37%, while for glutamates 38%, 17%, andRational protein surface engineering offers an effective
crystallization strategy through engineering of patches 45% (Baud and Karlin, 1999). Consequently, the K/E
clusters also show a tendency to occur with high proba-conducive to crystal-contact formation. Among the ex-
amples of successful application of this protocol, we bility in either helices or surface loops. Those in helices
may be less useful for engineering purposes becausenote a clear causal relationship between the type of
the mutations and the intermolecular contacts in the their main chain carbonyl and amide groups are en-
gaged in intrahelical H bonds and are not available forresulting crystals. The technique is readily applicable to
any soluble protein, using the QuikChange mutagenesis crystal contact interactions. Based on the examples of
successful applications, tight turns offer the best oppor-kit with primers introducing two or more mutations of
the K → A and/or E→A type, in sites located in relative tunities for crystal contact engineering. If structures of
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homologs of the target protein are available, they may nine mutants we obtained one crystal form, easily grown
from ammonium sulfate, which diffracted to 1.6 A˚ resolu-be used to facilitate the design of the mutations. Alterna-
tively, secondary structure predictions can be used to tion (Czepas et al., 2004). The refined structure shows
how the two arginines introduced on the surface in placelocate tight turns of up to six residues, containing Lys,
Glu, or both (Chou, 2000). of lysines mediate a key contact by sequestering sulfate
ions. In another study, we crystallized the N-terminal
domain of the human protein doublecortin by replacing2. Is Entropy Really the Underlying Factor?
two lysines with aspartates (M.H. Kim et al., submitted).There is no question that the removal of a charged, polar
One should note, however, that the principle of replacingamino acid, and its replacement with Ala, has diverse
large residues disfavored at protein-protein interfacesconsequences beyond the creation of a low-entropy
with smaller ones with lower conformational entropy issurface patch. However, we note that, in many examples
generally upheld. The advantage of alternative muta-given above, the results of mutagenesis are very consis-
tions is that they do not impact on a protein’s solubilitytent with the notion that entropic phenomena play a
as much as the alanine mutants.major role. Once a bulky side chain is removed, the
main chain carbonyls and amides become available to
mediate crystal contacts without excessive entropy 6. Is There a Danger of Destabilizing the Protein
loss, and indeed the crystal contacts occur precisely at by Removal of Charged Surface Residues?
the mutated sites. This would not necessarily be the Experimental studies showed that typically E → A mu-
case if electrostatic effects were dominant. However, tants are less stable than the wild-type protein (Mateja
both steric and electrostatic effects are bound to have et al., 2002). However, there appears to be no correlation
an impact, as can be inferred from the structure of the between stability of the mutant and crystal quality: the
CUE:ubiquitin complex (vide supra). E154A/E155A double mutant of RhoGDI, significantly
less stable than the wild-type protein, yields superb
3. Can the Protein’s Function Be Inadvertently crystals. Crystal quality is the derivative of the crystal
Affected by the Mutations? lattice formed by crystal contacts and does not appear
If one seeks structural insights into the protein’s known to be correlated with intrinsic thermodynamic stability
function, then obviously any mutants under investiga- of the protein.
tion should be assessed using a functional assay. A blind
application of the mutational approach to, for example,
7. Is the Structure of the Protein Affectedclass I aminoacyl-tRNA synthetases, which contain a
by the Mutations?functional motif KMSKS, would certainly lead to the en-
Comparative analyses of the several structures of K →zyme’s impairment. In our studies of the RGSL domain,
A and E → A mutants of RhoGDI reveal no differencesall mutants were assayed for their ability to bind G13
in the backbone conformation of magnitude exceeding(Longenecker et al., 2001b). In most cases, adequate
expectations based on the participation of these struc-data on functional residues exist to assist with the de-
tural elements in crystal packing epitopes. We believesign of the appropriate mutational strategy. On the other
that this result, as well as numerous other studies ofhand, when the structure is sought as the first step in
protein mutants, strongly suggests that the danger ofprotein’s characterization, i.e., in structural genomics
altering the local secondary structure by limited muta-projects, the availability of an atomic model of what
genesis is minimal.might even be an inactive mutant is still extremely valu-
able. As with all scientific experiments, the limitations
The examples of successful structure determinations,of the approach should always be born in mind and
based on crystals obtained using the rational surfacetaken carefully into consideration.
engineering protocol, suggest that the method bears
significant promise. As more examples emerge, it will4. Do the Mutations Reduce Protein’s Solubility?
be possible to refine the strategy to make it even moreAs might be expected, the K → A and E → A mutations
powerful and effective.almost invariably lower the protein’s solubility. This is
not inconsistent with the theoretical premises and not
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